[ad_1]
Although confirmation of the results is needed, the researchers believe that even a low level of efficacy would be more beneficial than the currently available medications for patients with Alzheimer's disease. The drug could not repair the damage already caused by the cognitive state, but slow down its progression.
[ad_2]
Source link
